Semax, a peptide fragment of adrenocorticotropin, has been the subject of clinical trials and studies investigating its efficacy in treating cognitive impairments. The peptide is known for its neuroprotective properties and has demonstrated potential in counteracting the inhibition of learning and memory induced by heavy metals, neurotoxic effects, and neurodegeneration caused by dopamine oxidation [3]. Studies have shown that Semax promotes the survival of neurons during hypoxia and glutamate neurotoxicity, increases the amount and mobility of immune cells, and enhances the expression of chemokine and immunoglobulin genes [3]. In a recent study on brain focal ischemia, Semax influenced the expression of genes that promote the formation and functioning of the vascular system, contributing to its neuroprotective role and mitochondrial stability under stress induced by the deregulation of calcium ion flow [3].
What the AI assistants say
The AI assistants collectively agree that Semax, a synthetic heptapeptide, has been the subject of clinical trials investigating its efficacy in treating cognitive impairments. They highlight that the strongest evidence for Semax’s efficacy comes from studies on stroke recovery and dyscirculatory encephalopathy, with evidence quality being moderate-to-weak by Western standards due to small sample sizes, limited independent replication, and mostly Russian publications. The AI assistants also concur that Semax’s mechanisms of action include BDNF upregulation, TrkB receptor activation, dopaminergic modulation, serotonergic enhancement, melanocortin receptor interaction, antioxidant effects, anti-inflammatory effects, excitotoxicity reduction, and anti-apoptotic effects.
AI assistants differ in their emphasis on specific aspects of Semax’s mechanisms and clinical evidence. Some focus more on the peptide’s neurotrophic effects and modulation of neurotransmitter systems, while others emphasize its antioxidant, anti-inflammatory, and direct neuroprotective effects. They also differ in their evaluation of the strength of the evidence, with some considering it strong in animal studies and others viewing it as moderate-to-weak in human clinical trials.
What the research actually shows
Clinical trials have investigated the efficacy of Semax in treating cognitive impairments, with findings suggesting its potential in promoting neuron survival, enhancing immune response, and influencing gene expression related to vascular health in the brain [3]. One specific clinical trial mentioned across the sources is a study on the effectiveness of Semax in counteracting the inhibition of learning and memory induced by heavy metals. This study highlighted Semax’s ability to promote neuron survival during hypoxia and glutamate neurotoxicity, which are common factors contributing to cognitive impairments [3]. Another trial focused on the influence of Semax on the expression of genes related to the formation and functioning of the vascular system in cases of brain focal ischemia, further emphasizing its potential role in treating cognitive impairments associated with vascular issues [3].
While the AI assistants’ consensus aligns with the research in recognizing Semax’s potential neuroprotective effects and its role in promoting neuron survival and vascular health in the brain, the research provides more specific details on the mechanisms and outcomes of the clinical trials. The research also emphasizes the need for further extensive research, including larger-scale clinical trials, to fully understand the efficacy and safety of Semax in treating cognitive impairments [3].
Bottom line:
Clinical trials have investigated the efficacy of Semax in treating cognitive impairments, with findings suggesting its potential in promoting neuron survival, enhancing immune response, and influencing gene expression related to vascular health in the brain. However, more extensive research is needed to confirm these effects.
References
- Boundless Upgrade Your Brain, Optimize Your Body and Defy — Ben Greenfield
- Can precision medicine be personal; Can personalized — Yechiel Michael Barilan
- EDR Peptide Possible Mechanism of Gene Expression and — Khavinson, Vladimir
- Effect of short peptides on neuronal differentiation of stem — Sergio Caputi
- Handbook of Biologically Active Peptides
- Neuroprotective Effects of Tripeptides—Epigenetic Regulators — Khavinson, Vladimir (author)
- Peptide Protocols Volume One — William A Seeds MD
- Principles of Geriatric Medicine and Gerontology
- Reversal of cognitive decline_ A novel therapeutic program
- Selenium_ Its Molecular Biology and Role in Human Health
- Super Agers An Evidence-Based Approach to Longevity — Eric Topol
Continue your research
Part of our Semax: Research Evidence & Trials guide.
- What clinical evidence supports the use of Semax in treating neurological disorders?
- What preclinical data support the use of Semax for cognitive enhancement?
- What preclinical evidence supports the use of Semax in treating anxiety disorders?
Related topics:
- What are the cognitive benefits of Semax administration in animal models?
- What are the potential benefits of Semax in treating neurodegenerative diseases?
- How does Semax compare to other peptide-based treatments in terms of efficacy and safety?